Sodium pentothal, the brand name for thiopental sodium, is an ultra-short-acting barbiturate used primarily to induce general anesthesia before surgery. It works within seconds of intravenous injection and was for decades the gold standard against which all other induction agents were measured.1PubMed. Pharmacodynamics and pharmacokinetics of thiopental Beyond the operating room, it has served roles in treating brain injuries, controlling severe seizures, sedating patients for medical imaging, and even in psychiatry and executions. Its reputation as a “truth serum” is probably its most famous cultural association, though the reality behind that label is far more complicated than Hollywood suggests.
How Thiopental Works in the Body
Thiopental produces its effects by enhancing the activity of the brain’s main inhibitory signaling system. It binds to receptors that, when activated, quiet neural activity, pushing the brain rapidly toward unconsciousness. One of its enantiomers (mirror-image molecular forms) is roughly twice as potent as the other at these receptors, which helps explain why the drug acts so quickly and powerfully even at modest doses.2PubMed Central. Stereoselective interaction of thiopentone enantiomers with the GABA(A) receptor
What makes thiopental “ultra-short-acting” is not that the body eliminates it quickly. The drug actually lingers in body fat for hours. The short duration of effect comes from redistribution: after injection, thiopental floods the brain and causes unconsciousness within 30 to 40 seconds, but it then rapidly moves out of the brain and into muscle and fat tissue, so the patient wakes up within minutes. This redistribution property is why a single dose can knock someone out fast but wear off fast, which made it ideal for the brief window needed to start anesthesia before switching to longer-acting agents.
Inducing General Anesthesia
The primary medical use of sodium pentothal has always been as an induction agent for general anesthesia. In clinical practice, an anesthesiologist injects a calculated dose into a vein, the patient loses consciousness in under a minute, and a longer-acting anesthetic or inhaled agent then takes over to maintain the surgical plane. This sequence made thiopental the workhorse of operating rooms from the 1930s through the early 2000s.
In a randomized trial comparing thiopental directly with propofol for anesthesia induction in adults, both drugs were clinically effective and safe. Propofol scored slightly higher on patient satisfaction (about 90% versus 85%), induced unconsciousness a bit faster, and patients recovered more quickly after the procedure. On the other hand, propofol caused a larger drop in blood pressure and heart rate, which can be a concern for patients with cardiovascular problems. Thiopental lowered blood pressure and heart rate too, but to a lesser degree.3Perioperative Care and Operating Room Management. Comparative study of Thiopentone and Propofol for induction of anaesthesia in adult population- a randomized clinical trial That gentler cardiovascular profile has kept thiopental in the conversation for patients who cannot tolerate steep blood pressure drops, even as propofol has become the default choice in most hospitals.
Cesarean Sections and Obstetric Use
Thiopental was widely used for emergency cesarean sections when speed was critical. Because it crosses the placenta, there were natural concerns about effects on the newborn. Research on elective cesarean deliveries found that at a standard dose of 3 mg/kg, thiopental did cross into the baby’s circulation, with the concentration ratio between newborn and mother rising over the first 8 to 10 minutes after injection. However, in low-risk elective cases, there was no appreciable difference in newborn outcomes compared with other induction agents like diazepam.4PubMed Central. Comparison of the placental transfer of thiopental and diazepam in caesarean section The key was keeping the time between induction and delivery short, which minimized how much drug reached the baby.
Sedation for Pediatric Procedures
Children who need to lie perfectly still for procedures like MRI scans often require sedation, and thiopental has been used for this purpose. A retrospective study of pediatric patients sedated with intravenous thiopental for MRI found that a starting dose of 3 mg/kg, topped up in small increments as needed, produced adequate sedation with an average total dose of about 5.6 mg/kg. Patients recovered in roughly 11 minutes after an average sedation time of about 32 minutes. None of the children experienced oxygen desaturation or required unplanned hospital admission.5PubMed Central. Efficacy and safety of intravenous thiopental for sedation during magnetic resonance imaging in pediatric patients: A retrospective analysis These findings illustrate why thiopental remained popular for short sedation in settings where the brief duration of action was a feature, not a bug.
Protecting the Brain After Serious Injury
One of thiopental’s most dramatic medical applications is in neurocritical care, particularly for patients with severe traumatic brain injury. When the brain swells after trauma, intracranial pressure can rise to dangerous levels. If standard treatments fail to bring it down, clinicians can induce a barbiturate coma using thiopental. This essentially puts the brain into a state of minimal metabolic demand, reducing its need for blood flow and oxygen, which in turn lowers the pressure inside the skull.
A study of children with traumatic brain injury found that barbiturate coma therapy significantly reduced intracranial pressure while preserving adequate blood flow to the brain.6PubMed Central. Temporal effects of barbiturate coma on intracranial pressure and compensatory reserve in children with traumatic brain injury The drug is also used after brain injuries caused by oxygen deprivation, such as those following cardiac arrest.1PubMed. Pharmacodynamics and pharmacokinetics of thiopental Barbiturate coma is considered a last-resort intervention because of serious side effects, including suppressed breathing, low blood pressure, and susceptibility to infections. Patients on barbiturate coma protocols require intensive monitoring in specialized units.
Treating Severe, Uncontrolled Seizures
When seizures do not respond to first-line and second-line medications, the situation is classified as refractory status epilepticus, a life-threatening emergency. Thiopental is one of the anesthetic agents used to stop these seizures by inducing deep sedation or coma. A Cochrane systematic review examining this use found that both thiopental and propofol are effective at halting refractory seizures, but concluded there is a substantial lack of evidence as to which drug produces better clinical outcomes overall.7PubMed Central. Propofol versus thiopental sodium for the treatment of refractory status epilepticus In practice, the choice between the two often depends on the patient’s cardiovascular status and what is available at the hospital. Both carry risks of prolonged ICU stays and the complications that come with being on a ventilator for extended periods.
Anesthesia for Electroconvulsive Therapy
Electroconvulsive therapy, or ECT, requires a brief period of general anesthesia to keep the patient comfortable and still during the procedure. Thiopental was a go-to induction agent for ECT for many years. Comparisons with propofol have shown some trade-offs: propofol tends to dampen the acute blood pressure and heart rate spikes that accompany ECT more effectively, and recovery is marginally faster. However, cognitive recovery afterward is similar between the two drugs. One study found propofol to be the better choice overall for ECT because it controlled the cardiovascular response more reliably.8PubMed Central. A comparison of propofol and thiopentone for electroconvulsive therapy That said, thiopental may allow slightly longer seizure durations during ECT, which some practitioners believe correlates with better therapeutic outcomes for the underlying psychiatric condition. The evidence on that point is debated.
The “Truth Serum” Reputation
Sodium pentothal became famous outside medicine as a supposed truth serum. The technique, formally called narcoanalysis, involves administering the drug intravenously to produce a drowsy, disinhibited state in which a person is thought to be more likely to disclose information they would otherwise withhold. The term narcoanalysis refers to applying psychotherapeutic principles while the patient is in a mild drug-induced sedated state.9Journal of Mental Science. Pentothal Sodium Narcoanalysis
The idea was taken up enthusiastically by military and intelligence agencies during and after World War II, and it entered popular culture through spy novels and films. The reality, though, is that thiopental does not compel truth-telling. What it does is lower inhibitions and create a suggestible state, similar in some ways to alcohol intoxication. People under the influence of the drug can still lie, confabulate, or respond to leading questions with whatever the questioner seems to want to hear. Courts in many countries have ruled narcoanalysis-derived statements inadmissible as evidence, and most modern psychiatrists consider the technique unreliable for fact-finding. It retains limited clinical relevance in some psychiatric settings for helping patients with conversion disorders or severe dissociative states access memories or emotions they have difficulty reaching in normal consciousness, but even this use has largely faded.
Risks, Side Effects, and Who Should Not Receive It
Thiopental’s side-effect profile is one reason it has gradually given way to newer agents. The most immediate concern is respiratory depression. The drug suppresses the drive to breathe in a dose-dependent fashion, which means it must always be administered in settings where airway management equipment and trained personnel are available. Blood pressure drops are common after injection, though they tend to be less dramatic than with propofol.
One particularly feared complication is accidental injection into an artery rather than a vein. The highly alkaline solution can cause severe tissue damage, vasospasm, and even gangrene if it enters an artery. Animal studies showed that intra-arterial thiopental injection causes significant tissue necrosis, with affected animals developing roughly 17 to 21 percent necrosis in the injected area.10PubMed. Deleterious effect of urokinase used to treat experimental intra-arterial thiopental injection injuries This risk drove strict protocols around careful IV placement and aspiration before injection.
Thiopental is also contraindicated in people with certain forms of porphyria, a group of metabolic disorders affecting the production of heme. A study of patients with inducible porphyrias found that porphyric symptoms worsened in seven out of ten patients who received thiopental, compared with two of four who did not. During an acute episode, thiopental can aggravate porphyric symptoms significantly.11PubMed. General anesthesia in “inducible” porphyrias For these patients, alternative anesthetic agents are essential. Other populations that require caution include people with severe cardiovascular disease, shock, Addison’s disease, and severe liver dysfunction, since the liver is responsible for metabolizing the drug.
Lethal Injection Protocols
Thiopental became widely known beyond medicine through its role in lethal injection protocols in the United States. In the standard three-drug protocol used by many states, thiopental (or later, pentobarbital) was administered first to render the prisoner unconscious, followed by a paralytic agent and then potassium chloride to stop the heart. An analysis of execution data from North Carolina found that the median thiopental dose used was about 20 mg/kg, with a range from roughly 11 to 44 mg/kg across 40 executions.12PubMed Central. Lethal Injection for Execution: Chemical Asphyxiation? These doses are far higher than the 3 to 5 mg/kg used to induce surgical anesthesia, but the study raised troubling questions about whether even these larger doses reliably maintained unconsciousness through the entire execution process, particularly given that the paralytic agent would mask any signs of awareness or pain.
The controversy around lethal injection and thiopental contributed to a chain of events that ultimately affected its availability worldwide. The sole U.S. manufacturer ceased production, and the European Union banned exports of thiopental intended for use in executions. This created supply shortages that rippled into legitimate medical settings, accelerating the shift to propofol and other alternatives for routine anesthesia.
Use in Euthanasia
In countries where physician-administered euthanasia is legal, thiopental plays a different end-of-life role. The process typically involves administering a barbiturate to induce deep unconsciousness, followed by a neuromuscular blocking agent that causes death through respiratory paralysis. A review of drugs used in assisted dying found wide variation in protocols, but thiopental doses for euthanasia typically range from 1 to 2 grams, vastly exceeding the amounts used for anesthesia.13PubMed Central. Efficacy and safety of drugs used for ‘assisted dying’ Dutch guidelines, for example, advise 2,000 mg of thiopental to induce coma before the muscle relaxant is given.14PubMed. Could it be a little less? Let the dose of thiopental in euthanasia depend on the body weight The emphasis in these protocols is on ensuring the patient is deeply unconscious and feels nothing before the lethal step.
Veterinary Anesthesia and Euthanasia
Thiopental has a long history in veterinary medicine as well, used for anesthesia induction in dogs, cats, horses, and other species. The drug’s rapid onset and short duration made it practical for brief surgical procedures and diagnostic work. Veterinarians valued it for the same redistribution properties that made it useful in human medicine. Barbiturates including thiopental also serve as euthanasia agents in veterinary practice, where a large intravenous overdose produces rapid loss of consciousness followed by death. As in human medicine, the drug’s availability has tightened over the years, and many veterinary practices have shifted to pentobarbital or other alternatives.
Why Sodium Pentothal Is Hard to Find Today
If thiopental was so useful for so long, you might wonder why it is rarely encountered in many countries today. The answer involves a tangled mix of pharmacology, politics, and economics. Propofol, introduced in the late 1980s, offered smoother induction, faster and more pleasant recovery, and less postoperative nausea. For most routine anesthesia cases, propofol simply performed better, and anesthesiologists gradually shifted their practice.
The lethal injection controversy accelerated this transition in ways nobody anticipated. When advocacy groups pressured manufacturers and European regulators restricted exports, the supply chain for thiopental collapsed. Hospitals that still used it for niche indications like barbiturate coma or refractory seizures found themselves scrambling for alternatives or importing the drug through increasingly uncertain channels. In some countries, thiopental remains available and in regular use. In others, it has essentially disappeared from hospital formularies. The drug’s story is an unusual case study in how a politically charged secondary use can reshape the availability of a medication whose primary purpose is entirely routine.
Thiopental in Resource-Limited Settings
While wealthier countries have moved on to propofol and newer agents, thiopental remains an important anesthetic in many low- and middle-income countries. It is cheaper to produce, does not require the cold-chain storage that some alternatives need, and is listed on the World Health Organization’s Model List of Essential Medicines. For hospitals in settings where propofol is expensive or inconsistently available, thiopental continues to be a practical, effective option for anesthesia induction. The irony is that supply disruptions driven by the lethal injection debate in the United States and Europe have at times made it harder to obtain even in places where it is a clinical mainstay, creating real consequences for surgical patients who have nothing to do with capital punishment politics.